Ocugen Expands COVAXIN™ Commercialization Rights to Include Canada
Ocugen, Inc. and Bharat Biotech today announced that they have entered into an amendment to their Co ...
Read moreOcugen, Inc. and Bharat Biotech today announced that they have entered into an amendment to their Co ...
Read moreThe National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, ...
Read moreBharat Biotech announced phase 3 interim analysis results of COVAXIN®. The second interim analysis is based ...
Read moreUnder Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.